SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-20-003875
Filing Date
2020-03-18
Accepted
2020-03-18 08:07:44
Documents
2
Period of Report
2020-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2245
2 ex24fuhrman.txt EX-24 3892
  Complete submission text file 0001179110-20-003875.txt   7600
Mailing Address C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Fuhrman Alan (Reporting) CIK: 0001303521 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 20723216

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations